Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Mechanisms of Therapeutic Resistance in Prostate Cancer
HTML
Details
Locations
Year:
2017
Type:
review
Source:
Current Oncology Reports
DOI:
10.1007/s11912-017-0568-7
Authors:
Mary Nakazawa,
Channing Paller,
Natasha Kyprianou
Institutions:
University of Kentucky,
Johns Hopkins University,
Sidney Kimmel Comprehensive Cancer Center,
University of Kentucky HealthCare
Language:
English
Topic:
Prostate Cancer Treatment and Research
Subfield:
Cancer Research
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
prostate cancer,
castration-resistant prostate cancer,
treatment resistance,
acquired resistance,
primary resistance,
molecular heterogeneity,
targeted therapy,
biomarker selection,
treatment sequencing,
combination therapy
show all 10
SDG:
Good health and well-being
Open Access status:
green
Funders:
University of Kentucky,
National Institutes of Health,
National Cancer Institute,
National Center for Advancing Translational Sciences
Awards:
Kentucky Center for Clinical and Translational Science,
Regional Oncology Research Center,
Overcoming drug resistance in metastatic castration resistant prostate cancer with a novel combination of TGF-beta inhibition and enzalutamide
OpenAlex ID:
W2589238818
FWCI:
1.342
Cites:
148
Cited by:
169
Related to:
10